Paid Clinical Trials New Orleans

Discover 567 paid clinical trials in New Orleans, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 567

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

New Orleans LA, Covington LA, Gulfport MS, Beaumont TXshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

SeladelparIntended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

Recruiting

PHASE3

Sponsor:

Gilead Sciences

Location:

New Orleans LA, Shreveport LA, Houston TX, Cordova TNshow 33 more

Code:

NCT06060665

Conditions

Primary Biliary Cholangitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Seladelpar 10 mg

Placebo

Amlitelimab with Topical CorticosteroidsA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

New Orleans LA, Gretna LA, Birmingham AL, Missouri City TXshow 45 more

Code:

NCT06224348

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Topical corticosteroids

Topical calcineurin inhibitors

AMZ001A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Recruiting

PHASE3

Sponsor:

Amzell

Location:

New Orleans LA, Longwood FL, Hialeah FL, Morehead City NCshow 3 more

Code:

NCT06693648

Conditions

Osteoarthritis of Knee

Osteoarthritis, Knee

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

AMZ001 Diclofenac gel

Placebo gel

NanO2™ & RadiationA Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

Recruiting

PHASE2

Sponsor:

NuvOx LLC

Location:

New Orleans LA, Kansas City MO, Peoria IL, Durham NCshow 7 more

Code:

NCT03862430

Conditions

Glioblastoma Multiforme

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NanO2TM

Placebo Saline Infusion

Talquetamab, Daratumumab, PomalidomideA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

New Orleans LA, Jackson MS, Houston TX, Little Rock ARshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Observational StudyMyriad™ Augmented Soft Tissue Reconstruction Registry

Recruiting

Sponsor:

Aroa Biosurgery Limited

Location:

New Orleans LA, Pensacola FL, Gainesville GA, Fort Myers FLshow 6 more

Code:

NCT05243966

Conditions

Abdominal Wound Dehiscence

Necrotizing Soft Tissue Infection

Lower Extremity Wound

Pilonidal Sinus

Anal Fistula

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Myriad Matrix™ and Myriad Morcells™

TX000045A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

Recruiting

PHASE2

Sponsor:

Tectonic Therapeutic

Location:

Covington LA, Jackson MS, Port Arthur TX, Beaumont TXshow 21 more

Code:

NCT06616974

Conditions

Pulmonary Hypertension

Heart Failure With Preserved Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TX000045- Dose A

TX000045- Dose B

Placebo

DAREDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Recruiting

PHASE2

Sponsor:

Criterium, Inc.

Location:

New Orleans LA, Atlanta GA, Oklahoma City OK, Columbus OHshow 10 more

Code:

NCT04567420

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Palbociclib

Fulvestrant

Adjuvant Therapy

TAR-210 vs. Intravesical TreatmentA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

New Orleans LA, Houston TX, Germantown TN, Little Rock ARshow 29 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

Text-Based ProgramReaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting

PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

New Orleans LA, Lafayette LA, Fort Smith AR, Cape Girardeau MOshow 160 more

Code:

NCT05008848

Conditions

Cigarette Smoking-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Smoking Cessation Intervention

Health Promotion and Education

Informational Intervention

Questionnaire Administration